| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0004 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |